These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20377775)

  • 21. Metabolic syndrome component combinations and chronic kidney disease: the severance cohort study.
    Cho JA; Lee SJ; Reid EA; Jee SH
    Maturitas; 2013 May; 75(1):74-80. PubMed ID: 23489551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population.
    Rashidi A; Ghanbarian A; Azizi F
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):976-83. PubMed ID: 17702729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.
    Kokubo Y; Okamura T; Yoshimasa Y; Miyamoto Y; Kawanishi K; Kotani Y; Okayama A; Tomoike H
    Hypertens Res; 2008 Nov; 31(11):2027-35. PubMed ID: 19098374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microalbuminuria and the metabolic syndrome and its components in the Chinese population.
    Lin CC; Liu CS; Li TC; Chen CC; Li CI; Lin WY
    Eur J Clin Invest; 2007 Oct; 37(10):783-90. PubMed ID: 17888089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
    Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
    Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study.
    Watanabe H; Obata H; Watanabe T; Sasaki S; Nagai K; Aizawa Y
    Diabetes Metab Res Rev; 2010 Jan; 26(1):26-32. PubMed ID: 20014332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
    Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
    Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study.
    Almeida OP; Calver J; Jamrozik K; Hankey GJ; Flicker L
    Am J Geriatr Psychiatry; 2009 Oct; 17(10):889-98. PubMed ID: 19910877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.
    Milionis HJ; Kostapanos MS; Liberopoulos EN; Goudevenos J; Athyros VG; Mikhailidis DP; Elisaf MS
    Int J Clin Pract; 2007 Apr; 61(4):545-51. PubMed ID: 17394429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I.
    Empana JP; Duciemetiere P; Balkau B; Jouven X
    Eur Heart J; 2007 May; 28(9):1149-54. PubMed ID: 17428821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.